Brazil suspends import of Lupin's antibiotic ingredients
Brazilian drug regulator ANVISA has suspended import of active ingredients produced by pharma major Lupin used to make antibiotics, citing "unsatisfactory inputs" and deviation from good manufacturing practices (GMP).
Jul 07, 2015, 20:42 PM IST
Lupin gets Board's nod to raise funds up to Rs 7,500 crore
Drug major Lupin on Tuesday said its Board of Directors have given in-principle approval for raising funds of up to Rs 7,500 crore.
Jun 23, 2015, 10:56 AM IST
Lupin Q2 net profit up 55% at Rs 630 crore
Drug major Lupin Tuesday posted 55.11 percent rise in its consolidated net profit at Rs 630.04 crore for the second quarter ended September 30, driven by robust sales in the US, Japan and domestic market.
Oct 28, 2014, 15:04 PM IST
